Beacon Pointe Advisors, LLC
- SEC CIK
- 0001744317
- Latest filing
- Aug 18, 2026
TRAW holding history
Traws Pharma, Inc. in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRAW overviewAll 13F holders of TRAWFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −509−100.0% | Sold outConverted for a 1-for-25 split | Holders |
| Q2 2024 | 12,714 | $5.68K | <0.1% | −1,062−7.7% | Reduced | Holders |
| Q1 2024 | 13,776 | $13.9K | <0.1% | −14,727−51.7% | Reduced | Holders |
| Q4 2023 | 28,503 | $21.3K | <0.1% | +73+0.3% | Added | Holders |
| Q3 2023 | 28,430 | $20.2K | <0.1% | +130.0% | Added | Holders |
| Q2 2023 | 28,417 | $33.5K | <0.1% | +15,286+116.4% | Added | Holders |
| Q1 2023 | 13,131 | $9.59K | <0.1% | −26,207−66.6% | Reduced | Holders |
| Q4 2022 | 39,338 | $25.4K | <0.1% | −9,624−19.7% | Reduced | Holders |
| Q3 2022 | 48,962 | $42.0K | <0.1% | −3,014−5.8% | Reduced | Holders |
| Q2 2022 | 51,976 | $68.0K | <0.1% | +5,949+12.9% | Added | Holders |
| Q1 2022 | 46,027 | $85.0K | <0.1% | +27,396+147.0% | Added | Holders |
| Q4 2021 | 18,631 | $48.0K | <0.1% | −7,809−29.5% | Reduced | Holders |
| Q3 2021 | 26,440 | $101.0K | <0.1% | +2,453+10.2% | Added | Holders |
| Q2 2021 | 23,987 | $166.0K | <0.1% | +23,987 | New | Holders |